Daily BriefsThematic (Sector/Industry)

Daily Brief Thematic (Sector/Industry): China Population Policies Impact on Healthcare Companies Series – Part 3 and more

In today’s briefing:

  • China Population Policies Impact on Healthcare Companies Series – Part 3
  • [Blue Lotus Daily]:LKNCY/1211 HK/XPEV/LI/NIO
  • [Blue Lotus Daily – TMT Update]: NTES/3690 HK/Bytedance/PDD


China Population Policies Impact on Healthcare Companies Series – Part 3

By Xinyao (Criss) Wang

  • Starting from November 1st 2023, Guangxi Zhuang Autonomous Region will include some therapeutic assisted reproductive medical services in the payment scope of basic medical insurance and work-related injury insurance funds.
  • Livzon’s 23Q3 performance was below expectations, which is related to China’s anti-corruption campaign started from 23H2. Considering the Chairman’s proposal to repurchase shares, we should be more patient with Livzon.
  • BGI is still digesting the impact of COVID revenue, and would experience a performance low point in 2023.However, BGI belongs to the direction of national key science and technology projects.

[Blue Lotus Daily]:LKNCY/1211 HK/XPEV/LI/NIO

By Eric Wen

  • LKNCY : Luckin Coffee offer special locations for franchisees (+)
  • XPEV: XPeng’s urban NOA function remains in the lead (+)
  • 1211 HK/XPEV/LI/NIO:  Huawei rumored to cease cooperation with major automotive portals such as Dongchedi (+)

[Blue Lotus Daily – TMT Update]: NTES/3690 HK/Bytedance/PDD

By Ying Pan

  • Bytedance/3690 HK: Douyin in-store GMV increased 256% YoY in 2023, miss target by 5% (+)
  • PDD: AliExpress to focus on expanding in the US market this year (-)
  • NTES: The latest developments about the reconciliation between NetEase and Blizzard (+)

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars